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Abstract 
Astrocytic excitability relies on cytosolic calcium increases as a key mechanism whereby astrocytes 
contribute to synaptic transmission and hence learning and memory. While it is a cornerstone of neurosciences that 
experiences are remembered because transmitters activate gene expression in neurons, long-term adaptive astrocyte 
plasticity has not been described. Here we investigated whether the transcription factor CREB mediates adaptive 
plasticity-like phenomena in astrocytes. We found that activation of CREB-dependent transcription reduced the 
calcium responses induced by ATP, noradrenaline or endothelin-1. As to the mechanism, expression of VP16-
CREB, a constitutively active CREB mutant, had no effect on basal cytosolic calcium levels, extracellular calcium 
entry or calcium mobilization from lysosomal-related acidic stores. Rather, VP16-CREB up-regulated sigma-1 
receptor expression thereby increasing the release of calcium from the endoplasmic-reticulum and its uptake by 
mitochondria. Sigma-1 receptor was also upregulated in vivo upon VP16-CREB expression in astrocytes. We 
conclude that CREB decreases astrocyte responsiveness by increasing calcium signalling at the endoplasmic-
reticulum-mitochondria interface, which might be an astrocyte-based form of long-term depression. 
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GPN, Gly-Phe-β-Naphthylamide  
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide  
CEPIA, calcium-measuring organelle-entrapped protein indicators  
PBS, phosphate buffered saline  
NGS, normal goat serum  
GPCR, Gq protein-coupled receptors  
MCU, mitochondrial calcium uniporter  
NAADP, nicotinic acid adenine dinucleotide phosphate  
MAM, mitochondria-associated ER membranes  
WT, wild-type 
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Introduction 
Calcium signals encode a wide range of physiological responses thanks to a diverse and extensive range of 
signalling components that can be activated upon receptor stimulation. In astrocytes, cytosolic calcium increases 
are largely the result of intracellular calcium mobilization due to activation of phospholipase C-β, with the 
consequent generation of inositol 1,4,5-trisphosphate (IP3) and the activation of IP3 receptors in the endoplasmic 
reticulum (ER). Calcium release from lysosome-related acidic vesicles through the generation of the second 
messenger nicotinic acid adenine dinucleotide phosphate (NAADP) [1, 2] and extracellular calcium entry also 
contribute to the final signature of each agonist-induced calcium responses in astrocytes [3]. Mitochondrial calcium 
uptake, which is coupled to IP3-induced calcium release [4], further shapes cytosolic calcium increases.  
The notion that calcium signals are a physiologically relevant sign of responsiveness in astrocytes has been 
demonstrated both in vitro and in vivo [5], leading to the widely-accepted notion that astrocytes display an action-
potential independent but calcium-dependent “excitability”. This feature allows them to couple neuronal activity to 
blood flow, maintain the blood-brain barrier, control ion, pH and transmitter homeostasis, provide metabolic 
support for neurons, and regulate synaptic transmission and memory-related processes [5-9]. It follows that 
astrocytic calcium signals may be tightly regulated such that their amplitude may be strengthened or diminished by 
neuronal or astrocytic activity. 
CREB belongs to a large group of transcription factors of the basic leucine zipper domain family and binds 
to the cAMP regulatory element (CRE) of target genes. In neurons, CREB is a key regulator of synaptic plasticity 
in various forms including long-term potentiation (LTP), intrinsic plasticity and in some cases, long-term 
depression (LTD) [10-12], all of which manifest as changes in the threshold, amplitude or frequency of action 
potentials thus changing synaptic strength. CREB is activated by phosphorylation by a variety of kinases including 
PKA —the best characterised one— PKC, mitogen- and stress-activated protein kinase (MSK1) and ribosomal 
protein S6 kinase (RSK2) [13-15]. Moreover, in neurons, CREB can be synergistically activated by increases in 
intracellular calcium followed by CAMKII activation, and by cofactors such as CTRC [16].  We recently described 
that CREB is also expressed in astrocytes where it can be activated by neurotransmitters in a calcium-independent 
mechanism [13]. 
In the present study we posit that transmitter-dependent long-term changes in cell responsiveness requiring 
gene expression are not an exclusive property of neurons. To address this hypothesis we examined whether CREB 
regulates transmitter-induced calcium responses in astrocytes given the importance of calcium signalling in these 
cells. CREB-dependent transcription was activated with ATP or noradrenaline (NA) or by expression of VP16-
CREB, a constitutive active form of CREB widely used to study CREB-induced LTP and intrinsic plasticity in 
neurons [17]. Calcium responses were elicited thereafter with different transmitters including ATP, which has a 
prominent role in astrocyte physiology. CEPIA calcium dyes targeting subcellular compartments, pharmacological 
manipulation of signalling pathways and calcium imaging of single cells were used to dissect out organellar and 
molecular mechanisms. We found a novel link between CREB and calcium signals, mediated by the sigma-1 
receptor at the mitochondria-associated membranes.   
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Materials and Methods 
Astrocyte culture 
Astrocyte  cultures were prepared from 1-day-old Sprague-Dawley rats following a previously described 
protocol [3]. Cells were plated in T150 flasks in DMEM medium supplemented with 10% fetal bovine serum 
(FBS), 20 U/ml penicillin, and 20 µg/ml streptomycin, and incubated at 37ºC in a humidified atmosphere 
containing 5% CO2. After reaching confluence, microglia were removed with mechanical shaking, and pure 
secondary astrocytes were seeded on new plates in the same medium. 
Adult astrocyte  cultures 
Adult astrocyte cultures were prepared from 8-week-old Sprague-Dawley rats. In brief, rats were sacrified 
and cerebral cortices isolated. After removing meninges, cortices were incubated with papain (2U/ml) and DNase 
(10 U/ml) for 15 min at 37ºC. Cell suspension was gentle triturated through a Pasteur pipette and filtered through a  
22 µM nylon mesh. Cells were collected by centrifugation at 500 g and plated into 24-well plates in DMEM/F12 
medium supplemented with 10% FBS, 20 U/ml penicillin, and 20 µg/ml streptomycin, and incubated at 37ºC in a 
humidified atmosphere containing 5 % CO2. The medium was replaced every 2 days and the cultures were used at 
8-15 days. 
Animal Model 
Transgenic mice with targeted expression of VP16-CREB in astrocytes conditional to gliosis (Gfa2-
tTa/TetO-VP16-CREB mice) [18] were used. They were kept under standard laboratory conditions (food and water 
ad libitum, 22 ± 2°C, a 12 h dark/light cycle, and 50 − 60% humidity and no administration of doxycycline). All 
experimental procedures were approved by the Animal Welfare Committee of the Universitat Autònoma de 
Barcelona and the Generalitat de Catalunya and were in agreement with the European Union Laws for the 
protection of experimental animals. 
Activation of CREB-dependent transcription 
Activation in cultures with transmitters: We used ATP (adenosine 5’-triphosphate magnesium salt), L-(-)-
norepinephrine bitartrate (NA), endothelin-1 (ET-1) or a L-glutamic acid monosodium salt (Glu), all of them 
purchased from Sigma Aldrich.  
Activation and inhibition in cultures with CREB constructs: We used three adenoviruses of serotype 5 
harboring a constitutively active CREB (Ad5-VP16-CREB), a dominant negative CREB (Ad5-ACREB), or no 
CREB construct (Ad5-Null). The expression of the transgenes was mediated by the CMV promoter. Infections 
were carried out in DMEM with 1% FBS using 1, 5, 30, and 100 multiplicity of infection (MOI). After 3 hours the 
medium was replaced by DMEM with 10% of FBS. All experiments were performed within 18 h-24 h after viral 
infections. No cellular death was detected up to 24 h after viral infections, as measured with 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction and Hoechst assays (data not shown).  
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Activation in vivo: To induce expression of VP16-CREB in transgenic mice, we followed a protocol to 
induce gliosis. Five-seven month-old mice under tribromethanol anesthesia were cryolesioned with a dry ice pellet 
following a previously described protocol [18]. Buprenorfin at 0.1 mg/Kg was injected i.p. every 12 h until its 
sacrifice at 1-3 days after the cryolesion. Female and male mice were equally distributed among experimental 
groups. 
Detection of CREB-dependent transcription by Luciferase:  
Astrocytes were transfected with 1 µg of plasmid pCRE-Luc and 0.5 µg of plasmid pTK-Renilla in 1% FBS-
containing DMEM using fugene 9 (Life Sciences). The plasmid pCRE-Luc (Promega) codifies for the luciferase 
gene under the control of a promoter that contains four CRE-sequences. After 48 hours luciferase luminescence 
was measured using the dual-luciferase reporter assay system (Promega) following the manufacturer’s instructions. 
Transfection efficiency was normalised by co-transfection with the pTK-Renilla plasmid, which codifies for the 
renilla protein under a constitutive promoter.  
Stimulation and pharmacological manipulation of calcium signals 
To induce calcium responses we used ATP, NA or ET-1, all purchased from Sigma Aldrich. To manipulate 
different signalling pathways we used carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) and BD-
1047 from Tocris, EGTA, and Gly-Phe-β-Naphthylamide (GPN) from Sigma Aldrich. Ned-19 was provided by Dr. 
Grant Churchill of Oxford University. All these compounds were applied 20 min before calcium imaging. 
Intracellular calcium measurements  
Cells were loaded with fluo-4AM (Thermo Scientific) at 4 µM and pluronic F-127 at 0.02% (Thermo 
Scientific) in Krebs Buffer with the following composition (in mM): 113 NaCl, 4.7 KCl, 25 NaHCO3, 1.2 MgSO4, 
10 Hepes, 1.3 CaCl2, and 10 glucose at pH 7.4. After 1h in the dark at room temperature, the cells were washed 
with Krebs Buffer, and transmitter-induced calcium responses were measured with a Victor III fluorometer (Perkin 
Elmer) or an Eclipse TE2000-E fluorescence microscope (Nikon) (excitation at 466-496 nm, emission at 520-550 
nm). Microscope images were collected and analysed with the MetaMorph image processing software (Universal 
Imaging).  
When fura-2AM was used, astrocytes were incubated with 2 µM fura-2-AM (Thermo Scientific) and BSA in 
Krebs Buffer for 1h in the dark at room temperature. After incubation, the coverslips were mounted in a static 
imaging chamber of an inverted epifluorescence Eclipse TE-2000U microscope (Nikon). The cells were excited at 
340 nm and 380 nm using a monochromator (Cairn Research), and fluorescence emission at 495-520 nm was 
recorded with an ORCA-ER CCD camera (Hamamatsu). Images were processed and analysed with the MetaFluor 
image processing software (Universal Imaging). Cell-based calcium calibration assays were performed to estimate 
calcium concentrations according to the method of [19]. 
Imaging of ER and mitochondrial calcium 
We used two plasmids encoding for calcium-measuring organelle-entrapped protein indicators (CEPIA), 
gifts from Masamitsu Lino, one for the ER (pCMV G-CEPIA-1ER, Addgene plasmid # 58215) and the other for 
the mitochondria (pCMV CEPIA-3mt, Addgene plasmid # 58219). 5 µg of the CEPIA constructs were transfected 
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using Amaxa nucleofector®. Two or three days after transfection with CEPIA plasmids, cells seeded on coverslips 
were mounted in a static chamber with Krebs Buffer in the epifluorescence Eclipse TE2000-U microscope stated 
above. The cells were excited at 476 nm and fluorescence emission was recorded at 510-560 nm. Images were 
analysed with the MetaFluor software. 
Alternatively, in a particular set of experiments, astrocytes were loaded with the mitochondrial calcium dye 
rhod-2AM (Life technologies) at 10 µM for 5 min at room temperature. The cells were excited at 552 nm and 
fluorescence emission was recorded at 570-640 nm. For each experiment, up to 60 single mitochondria were 
selected and mean of calcium increases were determined. 
Immunocytochemistry 
The cells were fixed with 4% paraformaldehyde in phosphate buffered saline (PBS) for 30 min at room 
temperature and permeabilised with PBS/0.1% Triton X-100 for 15 min. Nonspecific binding blockade was 
performed with 1% normal goat serum (NGS, Thermo Scientific) in PBS followed by overnight incubation at 4ºC 
with anti-GFAP (1/1,000 Dako) and anti-VP16 (1/500 Santa Cruz biotechnology) antibodies in 0.1% NGS-PBS. 
After washing, the cells were incubated for 1h with Alexa labelled secondary IgGs (1/1,000 in 0.1%NGS-PBS, 
Thermo Scientific).  
Western blots 
The cells were lysed on ice with RIPA solution containing 50 mM Tris-HCl, 150 mM NaCl2, 0.1% Sodium 
Dodecyl Sulfate (SDS), 1 % Nonidet P-40, protease inhibitor cocktail (Life Sciences), and phosphatase inhibitor 
cocktail (Sigma Aldrich). Protein concentrations were determined using Pierce BCA protein assay kit (Thermo 
Scientific). Equal amounts of protein (15-30 µg) were subjected to SDS 8-15% polyacrylamide gel electrophoresis 
and transferred to methanol-activated polyvinylidene fluoride membranes (Life Sciences). The membranes were 
blocked in 0.1% Tween 20-Tris buffer solution (TTBS) containing 5% milk for 1 h and incubated overnight with 
primary antibodies: 1/1,000 sigma-1 receptor (Thermo Scientific), 1/500 VP16 (Santa Cruz Biotechnology), 1/2000 
mitochondrial calcium uniporter (MCU, Abcam), 1/50,000 GAPDH (Thermo Scientific) and 1/20,000 β-Actin 
(Sigma Aldrich), diluted in 1% BSA-TTBS. Peroxidase-conjugated goat anti-rabbit and anti-mouse (Thermo 
Scientific) were used as secondary antibodies at 1/10,000 for 1h at RT. The bands were detected with an enhanced 
chemiluminescence detection kit (ECL) and developed by autoradiography on X-ray film (AGFA). 
Quantitative PCR 
Total RNA extraction was done using TRIZOL reagent following manufacturer’s instructions. Once purified, 
the mRNA was reverse-transcribed with RevertAid Reverse Transcriptase. Briefly, a reaction mix containing 1 µg 
RNA, 2 µM random hexamer primers, 2 µM Oligo(dT)18 Primers, 0.5 mM dNTPs, 0.45 mM 1,4-Dithiothreitol, 10 
U RNAseOut and 200 U RevertAid Reverse Transcriptase was incubated at 25ºC for 10 min, 42ºC for 60 min, and 
72ºC for 10 min. All reagents were purchased from Thermo Scientific. After RNA reverse transcription, the 
resulting samples at 1:25 or 1:100 dilutions were amplified in an Applied Biosystems 7500 Fast system using 
TaqMan reagents for SigmaR1, Mcu, Tbp and Gapdh genes (Thermo Scientific). We used LinRegPCR software to 
obtain average PCR efficiencies for each gene and then compared the Cq values with the comparative Cq method 
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[20]. Gene expression of sigma-1 receptor and Mcu in cultures were normalised to Gapdh and Mcu expression, 
respectively. In samples from mice, total mRNA extraction was performed after animals were sacrificed and the 
injured hemisphere was excised using a brain matrix as described in [18]; the expression of sigma-1 receptor was 
normalised to Tbp expression 
Statistical analysis 
Data are expressed as the mean ± SEM of a minimum of three independent experiments. Two datasets were 
compared using Student’s t test, whereas multiple groups were analysed using ANOVA and a Dunnet post-test if 
all groups were compared to control, or a Turkey post-test when all groups were compared to each other.  
Results 
Activation of CREB-dependent transcription regulates calcium signals 
To determine whether CREB changes astrocyte calcium signalling we used an experimental paradigm with 
two sequential interventions. The first one was applied to induce CREB-dependent transcription and consisted of 
transmitters (NA, ATP) or virally transduced VP16-CREB, a constitutively active form of CREB previously used 
in neurons [17] and other cell types [21,22]. The second intervention was aimed at directly examining excitability. 
To this end, we administered ATP, NA, or ET-1, three transmitters that are agonists of Gq protein-coupled 
receptors (GPCR), thereby activating the main intracellular calcium signalling pathways in astrocytes. 
We previously showed that long-term incubation with 10 µM NA or 100 µM ATP, but not with 100 µM 
glutamate, activated astrocytic CREB by an atypical PKC-dependent, calcium-insensitive mechanism [13]. In the 
present study, we resorted to 1-h pulses with the transmitters followed by a 5-h wait before the second stimulus to 
prevent alterations of calcium responses due to receptor desensitization. Calcium responses were examined with 
fluorimetry using the calcium dye fluo-4AM (Fig. 1a). Of note, agonist concentrations and duration of stimulation 
were set to achieve maximal CREB activation in our cultures while mimicking an activity-driven CREB activation 
in vivo. For example, micromolar concentrations of NA might be achieved under particular physiological and/or 
pathological conditions in vivo [23, 24]. At these concentrations, NA activates α– and β-adrenergic receptors [23], 
the latter being linked to gene transcription and plasticity in neurons [25]. 
Pulses of NA and ATP were able to stimulate CREB as shown with CRE-containing luciferase reporter 
assays, while glutamate (Glu) and ET1 had no effect (Fig. 1b). Accordingly, only CREB-activating 
neurotransmitters induced down-regulation of calcium responses (12-39%), suggesting that CREB mediates the 
actions of ATP and NA (Fig. 1c-h). Interestingly, the decreased calcium response was observed with all the 
transmitters tested (NA, ATP and ET-1) (Fig. 1c-h), suggesting that CREB targets core pathways of calcium 
signalling in astrocytes. In ensuing experiments we used 10 μM NA as the first stimulus and 100 μM ATP as the 
second. We selected the former because NA is a prototypical neurotransmitter acting through volume transmission 
and modulates the capacity of astrocytes to respond to local neuronal activity [26]. We selected ATP as the second 
stimulus because ATP drives intra- and intercellular calcium waves in astrocytes in cultures and in vivo, and is 
involved in many important physiological events [27-30]. Time-course analysis revealed that the reduction of 
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calcium responses was still present at 12 h but not at 24 h after incubation with NA (Fig. 2a-c), hence it was 
transient. Finally, we verified that the decreased response was due to CREB activation using virally-transduced A-
CREB, a well-known dominant negative construct of CREB [31]. 18 h after infection of cells with an empty viral-
vector (Null), ATP-induced calcium responses were smaller in cells pre-treated with NA; however, no differences 
were observed between NA and non-treated cells if astrocytes were infected with A-CREB (Fig. 2d-f). In other 
words, the presence of A-CREB abolished the NA-mediated reduction of ATP-induced calcium responses, 
confirming that it is a CREB-specific phenomenon. 
Before examining whether VP16-CREB reproduced the effect of physiological transmitters on calcium 
excitability, we confirmed the expression of the transgene with immunocytochemistry and western blot (Fig. 3a-b). 
The first technique allowed us to calculate that around 85% of astrocytes were infected by the VP16-CREB 
viral vector. Next we examined the effect of VP16-CREB on excitability using different MOIs of the virus. 
Astrocytes expressing VP16-CREB showed smaller ATP-induced calcium responses (20-30%) compared to 
astrocytes infected with the Null viral vector (Fig. 3d-e). The reduction of calcium responses was observed 18-24 
hours after infection and was independent of the vector concentration, whereas astrocytes infected with the Null 
vector responded as non-infected astrocytes (data not shown). VP16-CREB also decreased calcium responses to 10 
µM NA (Fig. 3f-g). Finally, we explored whether VP16-CREB expression changes basal intracellular calcium 
levels using the ratiometric calcium indicator fura-2AM. Astrocytes infected with the empty vector had a rest 
calcium concentration of 117 ± 8 nM whereas VP16-CREB expressing cells had 112 ± 5 nM (means of 3 
independent experiments), indicating that CREB did not exert any effect on basal calcium levels.  
Overall, this set of experiments demonstrates that CREB activation decreases transmitter-elicited calcium 
signals in astrocytes, while it does not interfere with basal calcium. 
Analysis of calcium fluxes  
We next studied the mechanism by which VP16-CREB regulates intracellular calcium responses, analyzing 
the contribution of calcium mobilization, extracellular calcium entry and calcium uptake mechanisms, in order to 
investigate if there is regulation of a specific signalling pathway or a general alteration of calcium homeostasis. As 
CREB does not abolish calcium responses but reduces them by 15-30%, we first analysed extracellular calcium 
entry and intracellular calcium release from lysosomes, which have an important but not major role in ATP and 
NA-induced calcium responses [3]. We infected astrocytes with VP16-CREB or Null viral vectors at 1-5 MOI and 
followed calcium responses with real-time fluorescence microscopy after treating astrocytes with 0.5 mM EGTA to 
chelate extracellular calcium, 50 µM GPN, a lysosomal disruptor, or 100 µM Ned-19, an inhibitor of the NAADP 
receptor [32]. All these pharmacological treatments diminished intracellular calcium responses in Null infected 
astrocytes, as previously described [3], but also in VP16-CREB expressing astrocytes (Fig. 3d and Fig. 4a-c). 
Therefore, the down-regulation of calcium by VP16-CREB compared to Null astrocytes was not altered (Fig. 4a-d). 
Thus, CREB does not appear to alter extracellular calcium entry or calcium mobilization from acidic vesicles.  
We then evaluated calcium release from the ER using G-CEPIA1er, a new calcium protein indicator that 
specifically localizes in the ER [33]. After co-expression of G-CEPIA1er and VP16-CREB, the cells were treated 
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with 100 µM ATP (Fig. 4e). As shown in Fig. 4f-g, VP16-CREB increased calcium release from the ER. This 
unexpected result proves that CREB does not reduce purinergic or GPCR expression, nor is there receptor down-
regulation or desensitization; however the observation is paradoxical because greater calcium release from the ER 
would cause an increase in cytosolic calcium. Since this is not the case, we reasoned that either calcium from the 
ER is not released to the cytosol, or there is a mechanism of calcium extrusion/uptake potentiated by CREB. We 
thus focused on analyzing calcium uptake by the mitochondria. First, we recorded the cytosolic calcium increase 
induced by 100 µM ATP after inhibition of mitochondrial calcium uptake with FCCP, an ionophore that transports 
protons through the inner mitochondrial membrane, and hence disrupts the electrogradient-driven calcium uptake. 
FCCP increased ATP-induced calcium responses so that VP16-CREB and Null astrocytes presented calcium 
responses of equal magnitude (Fig. 5a-b). Second, we directly measured mitochondrial calcium uptake using 
CEPIA3mt, a new low affinity green fluorescent mitochondrial calcium protein indicator [33] (Fig. 5c). VP16-
CREB astrocytes presented a greater mitochondrial calcium increase than Null astrocytes upon stimulation with 
100 µM ATP (Fig. 5d-e), in accordance with the FCCP data. Similar results were obtained using rhod-2/AM, a low 
affinity calcium dye that is preferably entrapped in the mitochondria. Calcium increases in individual mitochondria 
were 2.89 ± 0.7 times higher in VP16-CREB than in Null-infected cells.  
The sigma-1 receptor mediates the effect of VP16-CREB 
Taken together, these data indicate that VP16-CREB increases both calcium release from the ER and 
mitochondrial calcium uptake. These data would be reconciled if CREB activation were potentiating ER-
mitochondria interaction, a process that appears to be key for several cellular functions including calcium signalling 
[34]. Indeed, calcium transfer from the ER to the mitochondria through mitochondria-associated ER membranes 
(MAM) is initiated by the release of calcium from the ER following the production of IP3 [34]. MAMs integrate 
many different proteins. Among these, sigma-1 receptors have been shown to have a CREB-binding consensus 
sequence and to interact with the IP3 receptor [35]. We therefore studied whether VP16-CREB expression leads to 
increased expression of sigma-1 receptor with real-time PCR and Western blot. VP16-CREB-expressing astrocytes 
do have greater sigma-1 receptor mRNA and protein content than Null-infected cells (Fig. 6a-b). We then 
examined if sigma-1 receptor up-regulation contributes to the CREB-mediated effects on calcium fluxes. Pre-
treatment with of the sigma-1 receptors inhibitor BD1047 at 10 µM diminished the calcium release from the ER 
(Fig. 6c-d), and reduced mitochondrial calcium increases (Fig. 6e-f) in ATP-stimulated VP16-CREB-expressing 
astrocytes. All in all, the results provide evidence that the effects of VP16-CREB on calcium signalling can be 
mediated by the sigma-1 receptor and lend support to the following scenario: VP16-CREB raises the expression of 
the sigma-1 receptor thus amplifying the functional coupling between ER and mitochondria, increasing 
mitochondrial calcium uptake and thereby reducing cytosolic calcium.  
Sigma-1 receptor in the ER membranes can interact with different proteins of the outer mitochondrial 
membrane facilitating the flux of calcium, which might then be driven to the mitochondrial matrix through the 
mitochondrial calcium uniporter (MCU). Very little is known about regulation of MCU at transcription levels 
[36,37]. We therefore checked if VP16-CREB was also changing MCU expression. As shown in Fig 7a and 7b, 
MCU is expressed in astrocytes but paradoxically, VP16-CREB diminished its expression both at the mRNA and 
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protein level. We consider that this finding is in agreement with our previous observations that, in VP16-CREB 
expressing astrocytes, mitochondrial calcium uptake is increased but not to very high levels, therefore VP16-CREB 
induced MCU-downregulation might be a protective mechanism to avoid mitochondrial calcium overload and 
hence cell death. Moreover, the changed expression of MCU supports the notion that mitochondrial calcium uptake 
is exquisitely regulated by transmitter-induced gene expression.  
CREB-dependent transcription regulates calcium signals and sigma-1 receptor in adult astrocytes 
  The first demonstration of the implication of neuronal CREB in synaptic and plasticity was obtained in  
simple model systems like primary cell cultures from Aplysia ganglia [38, 39]. Above we reported the effect on 
CREB on astrocyte plasticity using primary cultures from neonatal astrocytes. Next, we sought to confirm key 
findings in cultured astrocytes from adult rats. Following the protocol stated in Fig. 1a, NA induced CREB 
activation by 368.7 ± 94.7% and this resulted in decreased ATP-induced calcium responses as shown in Fig. 8a and 
8b, much resembling the results in postnatal astrocytes. Reduction of ATP-induced calcium signals to the same 
extent was also achieved 18-24 hours after VP16-CREB infection compared to Null-infected astrocytes (Fig. 8c-d). 
In this case, the VP16-CREB viral vector infected around 78% of astrocytes. Finally, sigma-1 receptor was also 
upregulated upon VP16-CREB overexpression (Fig. 8e). We therefore checked if sigma-1 receptor is upregulated 
by CREB in vivo. To do so, we made use of transgenic mice where VP16-CREB is targeted to astrocytes. In such 
animals, CREB activation is driven by a gfap promoter and is not significantly increased in the forebrain in normal 
conditions (see [18] for a full characterization of the animals and VP16-CREB expression) but it is after a traumatic 
brain injury (cryolesion), which induces gliosis and hence activates the gfap promoter. Accordingly, as shown in 
Fig. 8f, sigma-1 receptor expression is slightly but not significantly different between wild-type (WT) and VP16-
CREB mice. Cryolesions upregulate sigma-1 receptor mRNA in both WT and VP16-CREB transgenic mice and, 
under such paradigm, VP16-CREB mice show a statistically significant higher expression of sigma-1 receptor 
compared to WT. Overall, these results suggest that VP16-CREB upregulates sigma-1 receptor in astrocytes in 
vivo.  
Discussion 
In the present study we provide evidence that transmitter-induced intracellular calcium responses, the basis 
of astrocytic excitability, are regulated by transmitter-triggered gene expression via the transcription factor CREB. 
Specifically, activation of CREB-dependent transcription in astrocytes by two transmitters, ATP and NA, or by a 
constitutively active CREB, reduces the calcium responses triggered by the GPCR agonists ATP, NA, and ET-1. 
The decrease of calcium responses is transient if the trigger of CREB-dependent transcription is transmitters given 
in pulses, consistent with the fact that transmitters produce a transitory activation of signalling pathways leading to 
CREB activation—namely CREB phosphorylation by kinases—while VP16-CREB bypasses such kinases and 
constantly activates CREB-dependent transcription. All in all, the data support the novel view that CREB regulates 
plasticity-like phenomena by targeting calcium signalling. Interestingly, CREB activation is independent of 
calcium in astrocytes [13], preventing self-depleting feedback negative loops. It will be of value to further extend 
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our results with experimental approaches that contemplate different magnitude and temporal patterns of CREB 
activation resembling a range of physiological or pathological conditions.  
As to mechanisms, VP16-CREB over-expression does not interfere with basal calcium concentration nor 
does it exert a wide alteration of GPCR or calcium-channel expression or activation, because there is no change in 
extracellular calcium entry or NAADP-driven calcium mobilization from acidic stores. Rather, studies with 
CEPIA-based organellar calcium dyes point to changes in calcium fluxes between ER and mitochondria as a central 
mechanism. Thus, we found that VP16-CREB enhances purinerigic-induced calcium release from the ER, increases 
mitochondrial calcium uptake, and enhances the expression of sigma-1 receptor, a protein interacting with IP3-
receptors at the MAMs [34]. These observations might not be mere coincidence. First, the inhibition of 
mitochondrial calcium uptake with FCCP prevents CREB from decreasing ATP-induced calcium responses, 
suggesting that mitochondria are the main uptake or extrusion loci involved. Second, the inhibition of the sigma-1 
receptor abolishes the increased ER-calcium release and lowers mitochondrial calcium uptake, demonstrating that 
sigma-1 receptors—whose gene has a CREB binding site [35]—mediates the effects of CREB. We also detected 
upregulation of sigma-1 receptor in cultured astrocytes from adult rats after infection with the VP16-CREB viral 
vector, and in transgenic mice with targeted activation of CREB in astrocytes. However, we cannot rule out the 
intervention of other CREB-dependent genes in the modulation of calcium responses in astrocytes. 
Importantly, the ATP-mediated mitochondrial calcium increases potentiated by VP16-CREB do not 
represent mitochondrial calcium overload because no cell death was detected after VP16-CREB expression, during 
the experimental times used in this study. In this sense, the decrease in the expression of the mitochondrial calcium 
uptake channel, MCU, induced by CREB may be a protective homeostatic change secondary to a more efficient 
coupling ER-mitochondria and confirms recently published data showing that CREB binds to the MCU promoter in 
chicken lymphocytes although in this case there is upregulation of MCU [40]. The CREB-dependent mitochondrial 
calcium rises in astrocytes may potentiate physiological functions such as oxidative phosphorylation or glutamate 
recycling and replenishment since enzymes such as alpha-ketoglutarate, isocitrate dehydrogenases, pyruvate 
dehydrogenase phosphatase, and ATP synthase are activated by mitochondrial calcium [41-42]. Accordingly, 
sigma-1 receptor stimulation in cardiomyocytes has been shown to reinforce calcium transport from the 
sarcoendoplasmic reticulum to the mitochondria and increase ATP production [43]. Although some authors support 
the idea that astrocytes are exclusively glycolytic, they have functional mitochondria and are capable of oxidizing 
glucose, fatty acids [44], and glutamate after its uptake from the synaptic cleft [6].  Thus, an adaptive and finely 
gene-regulated modulation of mitochondrial calcium, and hence of tricarboxylic acid cycle and ATP production, 
may be more important to astrocyte physiology than previously thought. 
It is noteworthy that CREB does not completely abolish intracellular calcium signalling in astrocytes but 
fine-tunes the response (i.e., decreases are 12-39%), suggesting that CREB also regulates non-mitochondrial based 
mechanisms such as gliotransmission [28]. Thus far, extensive ex-vivo and in-vivo evidence implicates calcium-
dependent gliotransmission in the regulation of synaptic transmission [45-48]—albeit with some controversy [5] 
but there was no evidence linking calcium-based astrocyte excitability and long-term plasticity. To our knowledge, 
this is the first report demonstrating that astrocytes, like neurons, do have long-term and transient intrinsic 
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plasticity-like phenomena or ‘cellular’ memory in terms of calcium responses. Although the idea of structural and 
functional plasticity of astrocytes has already been explored in other laboratories [49], previous reports dealt with 
short-term changes in gliotransmission (less than 30 minutes long), and these changes were, moreover, not 
mediated by a transcription factor and hence gene expression [50-51]. Because CREB reduces rather than increases 
astrocyte excitability, it appears that we might have discovered an LTD-like phenomena that may help memory 
consolidation by inducing a negative feedback loop that maintains neural networks in stable states or very long 
transients [52]. As noted in a recent review of 60 years of research in synaptic plasticity, the importance of memory 
and modulation in behaviour relies on the concept of plasticity per se rather than on the direction of the change in 
synaptic strength [53]. In any event, our results need further confirmation in vivo. 
 Finally, it is worth noting the therapeutic interest of the capacity of CREB to modulate calcium signals as 
these are involved in many and diverse physiological and long-term pathological events such as cardiac atrophy 
[54] or neuronal degeneration [55]. In astrocytes, calcium hyperactivity is a hallmark of epilepsy [27] and 
neurodegenerative diseases [29, 56]. In addition, we have recently reported that the targeted activation of CREB in 
astrocytes is beneficial in a model of acute brain damage [18] and here we provide evidence that sigma-1 receptor 
is upregulated by CREB in such context. Accordingly, disruption of IP3 receptor-mediated calcium release and 
activation of sigma-1 receptors are beneficial in animal models of stroke [57, 58]. Therefore, reduction of calcium 
signalling in astrocytes may be among the beneficial mechanisms switched on by CREB in several acute and 
chronic brain pathologies.  
In summary, two main conclusions can be drawn from the present study: 1) Calcium responses are regulated 
by transmitter-triggered CREB-dependent transcription, supporting the idea that not only neurons are endowed with  
plasticity-like phenomena, and 2) CREB-dependent transcription results in increased sigma-1 receptor expression 
and hence in a more efficient communication between ER and mitochondria. This may potentiate mitochondrial 
function, thus linking astrocyte energy metabolism and plasticity. 
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Figure legends 
Fig. 1 Pre-stimulation with CREB-activating transmitters reduces transmitter-induced calcium responses. 
(a) Schematic representation of the protocol used. (b) Activation of CREB-dependent transcription by different 
transmitters measured with a luciferase gene-reporting assay. Control are cells not treated with any transmitter but 
with vehicle; otherwise cells were stimulated with 100 µM ATP, 10 µM noradrenaline (NA), 10 nM endothelin-1 
(ET-1), or 100 µM glutamate (Glu) and CREB activity measured after 6 h. (c-h) Representative calcium traces (c, 
e, g) and quantification (d, f, h) of maximum increases after the addition of 100 µM ATP (c, d), 10 µM NA (e, f), 
or 10 nM ET-1 (g, h) after CREB activation with ATP, NA, ET-1 or Glu, identified with color codes.  (*) P < 0.05, 
(**) P < 0.01, (***) P < 0.001.  
Fig. 2. The transmitter-elicited reduction of cytosolic calcium responses is transient and CREB-dependent. 
Astrocytes were treated with 10 µM NA to induce CREB activation. Representative traces of calcium responses 
induced by 100 µM ATP at 12h (a) and 24h (b) after CREB stimulation. (c) Quantification of peak calcium 
responses induced by ATP after 6, 12 and 24 hours after CREB stimulation. The data are the means ± SEM of 3-4 
independent experiments. (*) P < 0.05, (***) P < 0.001. (d-e) Representative 100 µM ATP-induced calcium traces 
in single cells and (f) quantification of calcium responses after 6 h of stimulation of CREB with 10 µM NA in Null 
and A-CREB infected astrocytes. The data are the means ± SEM of 3-4 independent experiments. (**) P < 0.01.  
Fig. 3.  VP16-CREB decreases calcium responses induced by transmitters. (a) VP16 immunocytochemistry and 
(b) western blot of VP16 in astrocytes infected with VP16-CREB or Null viral vectors. (c) Schematic 
representation of the protocol used to measured calcium responses in astrocytes infected with VP16-CREB or Null 
viral vectors. (d, f) Representative single cell traces of calcium responses induced by 100 µM ATP (d) or 10 µM 
NA (f) in VP16-CREB-infected astrocytes (virus MOI 1). (e, g) Quantification of peak calcium responses at 
different viral vector loads. Data are normalised for the response of Null-infected astrocytes at the same viral vector 
load. The data are the means ± SEM of 4-7 (d) or 3-4 independent experiments (f) (*)P <0.05, (**)P <0.01.  
Fig. 4. VP16-CREB action on calcium signalling pathways. ATP-elicited elevation of calcium was tested in 
astrocytes transducing VP16-CREB with no added calcium and presence of 0.5 mM EGTA (0Ca2+), or in the 
presence of inhibitors of calcium release from acidic lysosomal-related stores: 50 µM GPN or 100 µM Ned-19. 
Control refers to cells without any treatment other than viral vector infection. Representative traces in single cells 
(a-c) and quantification (d) of 100 µM ATP-induced calcium responses in Null and VP16-CREB-infected 
astrocytes. The data are the means ± SEM of 6-8 independent experiments. (*) P<0.05, (**) P < 0.01. (e) 
Representative images of astrocytes transfected with the ER calcium dye G-CEPIA1er before and after 100 µM 
ATP application. Representative traces (f) and quantification (g) of the decrease in ER calcium. Data are means ± 
SEM of 4 independent experiments. (***) P < 0.001.  
Fig. 5. VP16-CREB increases mitochondrial calcium uptake. (a) Representative traces in single cells and (b) 
quantification of intracellular calcium responses induced by 100 µM ATP in Null and VP16-CREB-infected 
astrocytes in astrocytes treated with FCCP to inhibit mitochondrial calcium uptake. The data are the means ± SEM 
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of 4 independent experiments. (c) Representative images of the astrocytes transfected with the mitochondrial 
calcium dye CEPIA3mt before and after 100 µM ATP application. (d) Representative calcium traces and (e) 
quantification of 100 µM ATP-induced mitochondrial calcium increase in Null and VP16-CREB-infected 
astrocytes. The data are the means ± SEM of 4 independent experiments. (**) P < 0.01. 
Fig. 6. Sigma-1 receptor mediates the effects of VP16-CREB. (a) Quantification of sigma-1 receptor mRNA 
expression by quantitative PCR and (b) representative western blot of sigma-1 receptor in astrocytes infected with 
Null or VP16-CREB. (c) Representative calcium traces in single cells and (d) quantification of 100 µM ATP-
induced ER calcium decreases measured using G-CEPIAer in astrocytes infected with null or VP16-CREB viral 
vectors and in the absence and presence of BD1047, a sigma-1 receptor antagonist. (e) Representative calcium 
traces in single cells and (f) quantification of 100 µM ATP-induced mitochondrial calcium increases using 
CEPIA3mt in astrocytes infected with Null or VP16-CREB viral vectors and in the absence and presence of  
BD1047. The data are the means ± SEM of 3-4 independent experiments. (*) P < 0.05, (****) P < 0.0001. 
Fig. 7. MCU expression decreases in VP16-CREB expressing astrocytes. (a) Quantification of MCU mRNA 
expression in Null and VP16-CREB-infected astrocytes by quantitative PCR (a) Data are the means ± SEM of 3-4 
independent experiments. (****) P < 0.0001.  (b) Representative western blot of MCU in astrocytes infected by 
Null and VP16-CREB viral vectors.   
Fig. 8. CREB decreases calcium responses and upregulates sigma-1 receptor in adult astrocytes. (a) 
Representative traces (b) and quantification of calcium responses induced by 100 µM ATP after 6 hours of CREB 
stimulation (1 hour) with 10 µM NA or vehicle (control). (c) Representative traces and (d) quantification calcium 
responses induced by 100 µM ATP in adult cultured astrocytes infected with Null or VP16-CREB viral vectors. (e) 
Quantification of sigma-1 receptor mRNA expression by quantitative PCR in Null and VP16-CREB infected adult 
cultured astrocytes. In (b,d,e) data are the means ± SEM of 4 independent experiments. (*) P< 0.05. (f) 
Quantification by quantitative PCR of sigma-1 receptor mRNA expression in cortices in WT and VP16-CREB 
mice before (WT and VP16-CREB) and after cryolesion (WT C and VP16-CREB C). Cryolesions were performed 
to increase VP16-CREB expression in astrocytes conditional to gliosis. Data are the means ± SEM of 4-5 animals 
in each condition. (*) P < 0.05, (**) P < 0.01, (****) P < 0.0001. 
 
 
